Bottom line
BTLKX vs IEFA: the short answer
BTLKX (Baillie Gifford International Concentrated Growth Equities Fund) and IEFA (iShares Core MSCI EAFE ETF) are both mutual funds.
IEFA is cheaper at 0.07% vs 0.72% — a difference of $65 a year per $10,000 invested.
Over five years, IEFA returned +4.5% a year vs −0.6% for BTLKX (reporting dates differ).
Updated Nov 19, 2026
BTLKX vs IEFA side by side
| BTLKX | IEFA | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Baillie Gifford | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.72% | 0.07% |
| Annual cost per $10k | $72 | $7 |
| 10-yr cost on $10k (prospectus) | $1,015 | $90 |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +16.7% | +3.4% |
| 5-yr return (annualized) | −0.6% | +4.5% |
| 10-yr return (annualized) | — | +5.4% |
| Best quarter | +44.4% | +18.0% |
| Worst quarter | −24.1% | −23.5% |
| Net assets (fund) | — | $190.1B |
| Number of holdings | — | 2,632 |
| Portfolio turnover | 15% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
BTLKX and IEFA share none of their top holdings.
BTLKX top 10
IEFA top 10
- ASML Holding N.V. — 2.50%
- Hsbc Holdings Plc — 1.42%
- Roche Holding AG — 1.20%
- Novartis AG — 1.12%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.02%
- Nestle S.A. — 1.00%
- Astrazeneca Plc — 1.00%
- Shell Plc — 1.00%
- Siemens Aktiengesellschaft — 0.95%
- Mitsubishi UFJ Financial Group, Inc. — 0.93%
FAQ
What is the difference between BTLKX and IEFA?
BTLKX (Baillie Gifford International Concentrated Growth Equities Fund) and IEFA (iShares Core MSCI EAFE ETF) are both mutual funds. IEFA is cheaper at 0.07% vs 0.72% — a difference of $65 a year per $10,000 invested.
Which is cheaper, BTLKX or IEFA?
IEFA has the lower expense ratio (0.07%).
Should I own both BTLKX and IEFA?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.